SFX by Ex Libris Inc.

Title:	MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Source:	Nature [0028-0836] Steidl, C yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	GÃÃÂ¼nther, S. "Bidirectional binding of invariant chain peptides to an MHC class II molecule." Proceedings of the National Academy of Sciences of the United States of America 107.51 (2010): 22219-22224.
description	2.	Tolnay, M. "Complement receptor 2 in the regulation of the immune response." Clinical immunology and immunopathology 88.2 (1998): 123-32.
description	3.	Costello, R. "Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations." British journal of haematology 150.1 (2010): 21-7.
description	4.	Wilhelm, Brian T. "Defining transcribed regions using RNA-seq." Nature protocols 5.2 (2010): 255-266.
description	5.	Fahrer, Aude M M. "A mutation in a chromosome condensin II subunit, kleisin beta, specifically disrupts T cell development." Proceedings of the National Academy of Sciences of the United States of America 104.30 (2007): 12445-50.
description	6.	Marguerat, S. "RNA-seq: from technology to biology." Cellular and molecular life sciences 67.4 (2009): 569-579.
description	7.	Wold, B. "Mapping and quantifying mammalian transcriptomes by RNA-Seq." Nature methods 5.7 (2008): 621-628.
description	8.	da Rocha Fernandes, U. "IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes." Diabetes research and clinical practice 117 (2016): 48-54.
description	9.	Gaseitsiwe, S. "Identification of mhc class ii binding peptides: Microarray and soluble mhc class ii molecules." 2009. 417-426.
description	10.	Reich, M. "Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells." Cellular immunology 269.2 (2011): 96-103.
description	11.	Wong, Henry K. "Evolving Insights in the Pathogenesis and Therapy of Cutaneous T-cell lymphoma (Mycosis Fungoides and Sezary Syndrome)." British journal of haematology 155.2 (2011): 150-166.
description	12.	Goodnow, Christopher C C. "ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation." The journal of immunology (2006): 5337-46.
description	13.	Piva, R. "Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms." Journal of clinical oncology 28.9 (2010): 1583-1590.
description	14.	Kolesar, Shannon M. "Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma." American journal of health-system pharmacy 67.10 (2010): 793-797.
description	15.	Zee, YK. "Non-small cell lung cancer presenting with neoplastic fever at diagnosis and relapse." International Journal of Infectious Diseases; IJID 14.6 (2010): -21.
description	16.	Lee, Noraidah J. "BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations." British journal of haematology 144.5 (2009): 716-25.
description	17.	Eyles, Stephen J. "Nature's molecular sponges: Small heat shock proteins grow into their chaperone roles." Proceedings of the National Academy of Sciences of the United States of America 107.7 (2010): 2727-8.
description	18.	Landry, J. "RNA-Seq-quantitative measurement of expression through massively parallel RNA-sequencing." Methods 48.3 (2009): 249-257.
description	19.	Guerin, Leigh R. "Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?" Human reproduction update 15.5 (2009): 517-535.
description	20.	Dyson HJ, Kostic M, Liu J, Martinez-Yamout MA;, H.J. J. "Hydrogen-deuterium exchange strategy for delineation of contact sites in protein complexes." FEBS letters 582.10 (2008): 1495-1500.